Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Familial ependymoma × Temozolomide × Clear all

Sponsor

Conditions

Glioblastoma 104 Brain Neoplasms 50 Gliosarcoma 48 Glioma 42 Central Nervous System Neoplasms 28 Astrocytoma 27 Melanoma 21 Oligodendroglioma 14 Neuroblastoma 10 Neoplasm Metastasis 8 Ependymoma 7 Recurrence 6 Neoplasms 6 Sarcoma, Ewing 5 Lymphoma 5 Spinal Cord Neoplasms 4 Skin Neoplasms 4 Sarcoma 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Medulloblastoma 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Somatostatinoma 3 Gastrinoma 3 Colorectal Neoplasms 3 Carcinoma, Islet Cell 3 Uveal Melanoma 2 Rhabdomyosarcoma 2 Pinealoma 2 Pancreatic Neoplasms 2

Interventions

Magnetic Resonance Spectroscopy 2 Everolimus 2 Erlotinib Hydrochloride 2 ribociclib 1 palbociclib 1 olaparib 1 etoposide phosphate 1 erdafitinib 1 X-Rays 1 Sunitinib 1 Specimen Handling 1 Radiotherapy 1 Phantoms, Imaging 1 Nuclear Medicine Department, Hospital 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Microarray Analysis 1 Lapatinib 1 Irinotecan 1 Immunologic Techniques 1 Immunohistochemistry 1 Immunoglobulin G 1 Ifosfamide 1 Fluorodeoxyglucose F18 1 Etoposide 1 Donepezil 1 Disulfides 1 Dasatinib 1 Cyproheptadine 1 Carboplatin 1 Blotting, Western 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡